Private investment advisory firm Sun European Partners has appointed Dr Mark Braganza as managing director on the transactions team, based in London.

Braganza has more than 15 years’ experience investing in multiple healthcare investment strategies, structures and subsectors. He was previously a founding member and partner of GHO Capital, a European healthcare-focused mid-market private equity business which he joined after eight years in the healthcare team at TPG, in both San Francisco and London. Before that, Braganza worked in biotechnology with Chiron Corporation, as a management consultant with the Boston Consulting Group, and as a doctor in the NHS. He is a trustee at Restore, a charity enabling basic research to improve the lives of burns and scar patients.

Mark Corbidge, head of private equity in Europe, and managing director at Sun European Partners, said: “We are delighted to have Mark join our transactions team and help us spearhead our expansion into European healthcare. Sun has a strong position in the US healthcare market, with recent and prior investments such as ClearChoice, Clinical Care Medical Centers, West Dermatology and Simply Beautiful Smiles.”

Braganza said: “I look forward to working with the Sun European team to source investment opportunities in the exciting European healthcare market. It’s a fantastic opportunity to build on the firm’s strong track record in the US healthcare sector, applying Sun European’s operational expertise to develop a leading healthcare profile and portfolio in Europe.”

Sun European focuses on defensible businesses in growing markets with tangible performance improvement opportunities in the business services, consumer, healthcare, industrial, and technology sectors. The company has offices in London and affiliates with offices in Boca Raton, Los Angeles, and New York.